AstraZeneca and Honeywell to develop sustainable NextGen inhalers
Category: #energy-and-environment  By Pranali Mehta  Date: 2022-02-28
  • share
  • Twitter
  • Facebook
  • LinkedIn
AstraZeneca and Honeywell to develop sustainable NextGen inhalers

The collaboration aims to develop net zero impact respiratory inhalers

Cambridge-based pharma & biotech company, AstraZeneca has teamed up with U.S. conglomerate Honeywell to design next generation inhalers with least possible environmental impact.

Reportedly, the propellant (HFO-1234ze) used in the novel inhalers is 99.9% less capable of contributing to global warming as compared to the existing propellants used in respiratory medicines.

The announcement comes adjacent to the release of the annual sustainability report which demonstrates growth of AstraZeneca’s flagship programme ‘Ambition Zero Carbon’.

Essentially, the report highlights AstraZeneca’s primary energy or electricity source to be renewable in nature noting a 59% reduction in the company’s Scope 1 and 2 greenhouse gas (GHG) emissions in last 6-7 years.

Moreover, the report also promotes the pharma player’s initiative to combine Alexion’s GHG footprint.

Speaking on the vested interest in sustainability, AstraZeneca CEO Pascal Soriot mentioned that the company is striding to achieve its zero carbon goals across global operations by 2025 end followed by the carbon negative target for the entire value chain by 2030.

With Honeywell collaboration, AstraZeneca has reaffirmed its commitment to boost sustainable healthcare innovation with the view of enhancing patient experience and feedback, whilst curbing environmental footprint.

Honeywell CEO and Chairman, Darius Adamczyk commented on the opportune deal stating that the initiative to develop a respiratory inhaler that deploys new net-zero Global Warming Potential propellant, is extremely crucial for the environment as well as patients suffering from respiratory issues.

The primary goal, as Honeywell likes to frame it, is to diminish respiratory healthcare CO2 emissions without compromising on healthcare outcomes or patient choice.

Respiratory diseases like asthma or chronic obstructive pulmonary disease necessitate nasal pathways to give medicines, typically comprising of pressurized metered-dose inhalers (pMDIs) which are packed with limited quantities of certain GHG that propels the medicine into the lungs.

Imperative to note that the first-in-human Phase I trial of HFO-1234ze demonstrated positive results with apt safety and tolerability with systemic exposure of active molecules unlike alternatives.

Source Credit: https://www.businessweekly.co.uk/news/biomedtech/astrazeneca-and-honeywell-pioneer-near-net-zero-inhalers

  • share
  • Twitter
  • Facebook
  • LinkedIn

About Author

Pranali Mehta

Pranali Mehta    

Pranali Mehta boasts of over three years of experience as a content writer. Having completed her graduation in chemical engineering, she worked as safety & environment associate in a chemical company for a year. Harnessing her passion for writing however, Pranali deci...

Read More >>

More News By Pranali Mehta

KKR to acquire renewable energy firm ContourGlobal for £1.75Bn
KKR to acquire renewable energy firm ContourGlobal for £1.75Bn
By Pranali Mehta

ContourGlobal, a British power generation firm, has recently accepted a private equity takeover at a time when the demand for greener energy is increasing due to market turmoil caused by the Ukraine conflict. According to sources, the company has ...

Tata Power obtains a huge solar project from NHPC worth $223Mn
Tata Power obtains a huge solar project from NHPC worth $223Mn
By Pranali Mehta

Tata Power, an electric utility firm based in India, has recently obtained a solar project worth Rs 1,731 crore ($223 million) from NHPC (National Hydroelectric Power Corporation). According to sources close to the move, the wholly-owned division ...

Tamkeen enters strategic partnership with Bank of Bahrain & Kuwait
Tamkeen enters strategic partnership with Bank of Bahrain & Kuwait
By Pranali Mehta

Bahrain-based government agency, Tamkeen has recently inked a new strategic partnership agreement with the Bank of Bahrain and Kuwait (BBK) in a row with novel support programs. Incidentally, the agreement is an addition to the partnership agreeme...